What is Canary Speech?
Based in Utah, Canary Speech stands as a global leader in the speech digital biomarker sector. By leveraging patented artificial intelligence, the company performs sophisticated vocal analysis on as little as 20 seconds of speech. This technology is engineered to serve critical sectors including hospital systems, health and wellness platforms, and the pharmaceutical industry. By integrating these capabilities into telemedicine and remote medical services, Canary Speech is effectively bridging the gap between diagnostic precision and patient accessibility, ultimately aiming to enhance quality of life and clinical outcomes on a global scale.
How much funding has Canary Speech raised?
Canary Speech has raised a total of $13.1M across 2 funding rounds:
Debt
$120K
Series A
$13M
Debt (2021): $120K with participation from PPP
Series A (2024): $13M led by Sorenson, Cortes Capital, and Hackensack Meridian Health
Key Investors in Canary Speech
Sorenson
Sorenson is a global leader in language services and accessible communication, specializing in connecting signed and spoken languages through patented technology and human-centric services.
Cortes Capital
Cortes Capital is a diversified investment firm that provides comprehensive real estate services, property management, and strategic financial advisory to a broad client base.
Hackensack Meridian Health
Hackensack Meridian Health is a premier not-for-profit healthcare network in New Jersey, recognized for its integrated medical services, innovative research, and commitment to life-enhancing patient care.
What's next for Canary Speech?
The infusion of capital from this major strategic investment positions Canary Speech to scale its operations significantly within the enterprise healthcare landscape. Moving forward, the company is expected to prioritize the expansion of its clinical validation studies and the integration of its vocal biomarker technology into broader pharmaceutical research pipelines. As the healthcare industry shifts toward proactive, data-driven patient monitoring, Canary Speech is well-positioned to capitalize on the demand for non-invasive, remote diagnostic tools. The strategic alignment with its current investor base provides the necessary infrastructure to navigate complex regulatory environments and accelerate the commercial deployment of its proprietary AI solutions.
See full Canary Speech company page
